type full_text Clinical Summary [REDACTED] [REDACTED][REDACTED] 81 yo Female ChineseNKDAADL i, home ambulant with walking stickStays with [REDACTED] and daughter in [REDACTED] Past Medical History 1. AF, not on anticoagulation Echo (Feb 2021): Normal LVEF, High probablity of PHT PASP 51 mmHg Apixaban discontinued on 10/08/21 after discussion with family in view of high falls risk 2. Dementia 3. Hypertension 4. Hyperlipidaemia 5. Non DM nephropathy HbA1c (Feb 21) 5.9 6. Osteoporosis 7. Thalassemia 8. Recurrent falls 9. Incidental finding of stable small ?meningioma Covid Vaccination 1 st dose: 20/8/2021 Pfizer 2 nd dose: 14/9/2021 Pfizer Previous Admission SKH November 2021:1. Fall complicated by (a) Left NOF s/p left hip bipolar hemiarthroplasty (uncemented) 2/11/21(b) L 2 compression fracture possibly old 2. ARU 3. Incidental finding of stable small ?meningioma History of Presenting Complaint Noted patient minimally communicative DementiaCorroborative Hx from Son taken in ED:1. COVID PCR positive (20 Jan 2022)CT value: 16.17 | 16.41 Onset of symptoms : (date if any)( ) Fever ( ) Chills( ) Cough 3/7 (19/1/22)( ) Phlegm ( ) Sore throat ( ) Runny nose 2/7 (20/1/22)( ) Ageusia( ) Anosmia( ) Breathless( ) Chest pain( ) Dysuria( ) DiarrhoeaBaseline able to feed and shower herselfAble to communicate with son and ambulates independently Objective Vitals in EDT 39.2 C BP 116/72 HR 114 RR 22 SpO2 97 on RA Vitals in WardT 37 HR 99 BP 110/98 SpO2 97 on 2 L NPAlert, comfortableHeart S 1 S 2 Lungs creps heard over basesAbdomen not distended, soft, non tender, no guarding, no rebound tenderness, renal punch ve no masses, bowel sounds activeCalves supple, no pedal oedema BMI: 22.0 Initial Investigations COVID PCR positive (20 Jan 2022)CT value: 16.17 | 16.41 LDH NADECG Afib, nil acute ischemic changes notedTrops 18 Ur 7.2 Na 134 K 4.6 Bicarb 22.3 Cr 103 Nil raised LFTsCRP 70.1 Hb 12 TW 12.73 Plt 345 CXR: There is upper lobe pulmonary venous diversion. Linear atelectasis in both lower zones. Mild patchy air space shadowing in the right lower zone may also represent pulmonary venous congestive changes. In ED Blood cultures takenCoVID swab takenGiven IV paracet, IV augmentin, PO Clarithromycin Issues and Progress 1. Mild to Moderate COVID 19 infection Risk factors for progression: Age >55 / CKD Date of symptom onset : 19/1/22 Date of first positive PCR on (20 Jan 2022), CT value: 16.17 | 16.41 Repeat COVID PCR (D 7) positive, CT 22.3 | 21.7 SARS CoV 2 Nucleocapsid Ab negative Spike Ab positive (291) Fully Vaxxed (2 doses), latest dose on 14/9/2021 Pfizer CXR: There is upper lobe pulmonary venous diversion. Linear atelectasis in both lower zones. Mild patchy air space shadowing in the right lower zone may also represent pulmonary venous congestive changes. ISARIC Score: 11 (Age 7, Comorbids 1 [DM], RR 1 [20], Urea 1 [7.2] CRP 1 [70.1]) Blood c/s (21/1/22) prelim NBG Empirically treated with PO augmentin (starting 22/1 and IV augmentin 23/1 24/1 treated with IV remdes and IV Dexa for 5 days (22/1/22 26/1/22)2. Allied heath review ST reviewed for oral diet PT (24/01): Mod assist for short distance ambulation, function similar to baseline OT(24/1): assisted for ADLs by son (carer training done in Nov 2021 at SKCH). Generally moderate to maximal assistance for BADLs Patient discharged stable to home on 27/1/22 on D 8 of infection (time based discharge)EOC: Not for CPR/Intubation, for escalation to HD/ICU for HFNC/inotropes as needed TCU Plans Keep existing TCUs Care Plan Keep existing TCUs